Shigellosis pathophysiology

Shigellosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Classification
Causes
Differentiating Shigellosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Shigellosis pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Shigellosis pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Shigellosis pathophysiology
CDC on Shigellosis pathophysiology
Shigellosis pathophysiology in the news
Blogs on Shigellosis pathophysiology
Directions to Hospitals Treating Shigellosis
Risk calculators and risk factors for Shigellosis pathophysiology

Pathophysiology

Transmission

• A small inoculum (10 to 200 organisms) is sufficient to cause shigellosis.
• Most commonly, shigella is reported to be easily spread by the fecal-oral route in regions of poor sanitation.
• Epidemics may be foodborne or waterborne.
• Shigella can also be transmitted by flies and sexual contact.

Cellular Pathogenesis

The small inoculum may be attributed to the following features of the organism:

• Shigella contains acid resistance systems that enable the organism to survive the acidic environment in the stomach.(61)
• Shigella can downregulate the expresion of antibacterial proteins released by the host (human) intestinal mucosa.(118)

Phase 1:Transcytosis Using M Cells As Entry Ports

Shigella migrates to the large intestine, where it causes infection via invasion of the epithelial barrier of the large intestine. Initially, Shigella uses M cells from the basolateral side of the intestinal epithelium as entry port.(250,325) M cells are specialized cells that sample the gut lumen for pathogenic antigens and delivers these antigens to mucosal lymphoid tissue to activate an adequate immune response.(157). Shigella is transcytosed across the epithelial layer of the intestinal M cells.

Phase 2:Uptake by Macrophages

• Following transcytosis, Shigella enters macrophages and induces cellular apoptosis.
• Macrophage apoptosis results in the release of pro-inflammatory cytokines (IL-1-beta and IL-18)), which signal intestinal inflammation and consequent innate immune response.

Phase 3: Release from Apoptotic Macrophages

• Following apoptosis and inflammation, Shigella is released from the macrophages.
• Invasion of the intestinal epithelium continues from the basolateral side, and the bacteria further spreads to adjacent epithelial cells and avoids extracellular exposure by using intercellular actin polymerization processes (rocket propulsion).

Phase 4: Infiltration of Polymorphonuclear Neutrophils

• As Shigella infiltrates the epithelial cells, activation of nuclear factor kappa-B (NF-KB) by Shigella generates IL-8, which in turn mediates the recruitment of polymorphonuclear neutrophils (PMN) to the site of inflammation.
• PMN destroy the integrity of the intestinal epithelial barrier and allow more Shigella organisms to directly and more easily invade the intestinal epithelium. The loss of the intestinal epithelial cells results in impaired adsorption of other nutrients and fluids and leads to clinical manifestations of shigellosis (diarrhea).
• Shigella enterotoxin 1 (ShET1) and enterotoxin 2 (ShET2) are synthesized during the inflammatory process and are thought to account, at least in part, for fluid secretion that results in shigellosis-associated diarrhea.
• Other Shigella toxins, such as Shigella dysenteriae serotype 1 toxin, results in cytotoxicity and development of vascular lesions at the level of the colon, the kidneys, and the central nervous system. The cytotoxic activity of the toxin is thought to cause shigella-associated complications, such as hemolytic uremic syndrome (HUS).

Ultimately, more PMN are recruited and Shigella organisms are killed.

Gross Pathology

On gross pathology, shigellosis is typically associated with acute-onset diffuse fibrinous exudative inflammation in the colon and the rectum. The following histopathological features may be observed:

• Ulcer formation and focal erosions
• Necrotizing inflammation
• Hyperemia
• Edema

Microscopic Pathology

On microscopic histopathological analysis, the following findings may be observed from samples of the colon, rectum, and occasionally the distal ileum:

• PMN infiltration
• Formation of patchy inflammatory pseudomembrane (epithelium, neutrophils, and fibrin)

The following video demonstrates the microscopic pathological features of shigellosis: {{#ev:youtube|1D1m4rybDrc}}

References

Template:WikiDoc Sources